streep tussen2


European HIV Hepatitis Testing Week starts on the 17th of November

Get all info about Hepatitis testing, testing technologies, guidance for communication and downloadable info sheets and checklists at

streep tussen2


No elimination without decriminalization!

Correlation Network, together with many other community organisations, signed a declaration on the elimination goals for hepatitis c in the light of continuous stigmatisation and decriminalisation of affected communities. Despite WHO recommendations identifying harm reduction as one of five core interventions to reach the goal of viral hepatitis elimination by 2030, in many countries, comprehensive harm reduction services continue to be largely inaccessible, with barriers to services driven by punitive drug law enforcement laws and policies.

You can read the full declaration



streep tussen2


European HIV/HCV Testing Week - get support by Correlation

testing weekIf your organisation is interested to participate in European HIV/HCV Testing Week, November 17 - 24, 2017 please let us know now.  Correlation Network will support your organisation to participate by providing technical assistance, capacity building support, HCV trainings and we can give you a limited amount of Orasure oral HCV test kits.
Jason Farrell This email address is being protected from spambots. You need JavaScript enabled to view it. or
Eberhard Schatz This email address is being protected from spambots. You need JavaScript enabled to view it. 
for request and consult: 
for more information about testing week.


streep tussen2


Safe, voluntary testing for key and most affected populations

Correlation signed a joint statement from key population networks, regional networks, HIV and Hepatitis organisations


streep tussen2


Launched at an event in the European Parliament today,

the ACHIEVE (short for Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe)

coalition calls on the EU to take action to eliminate viral hepatitis B and C by 2030 in the WHO European Region, in line with the WHO Global Health Sector Strategy on viral hepatitis, the WHO Europe Action Plan, which build on and the UN Sustainable Development Goals (SDGs).

The ACHIEVE coalition includes the following organisations: The European Liver Patients’ Association (ELPA), the Viral Hepatitis Prevention Board, Hepatitis B and C Public Policy Association, EASL International Liver Foundation, European Aids Treatment Group (EATG), Correlation Network, the World Hepatitis Alliance and the Barcelona Institute for Global Health (ISGlobal). It is enabled by the support of Abbott, CEPHEID, Gilead Sciences and MSD.

For more information


streep tussen2


Hepatitis C Civil Society Declaration launched

At the Hepatitis C Community Summit in Amsterdam, civil society and community organisations from all over Europe launched a declaration to address the urgent need for civil society involvement in HCV policy and practice. Only with the collaboration of all and by combating stigma and discrimination, can the elimination of HCV be a realistic goal.

Please read the declaration here and share widely


streep tussen2


Hepatitis B and C testing: Why? Who? How?

A guidance paper on testing in community and harm reduction settings

testing paper webThis paper aims to stimulate services to engage in HCV and HBV awareness raising and in particular to inform community members, social and health care practitioners about current HBV/HCV testing and diagnosis methods, screening technologies and other aspects around the issue.





streep tussen2

The aims of the Correlation Berlin Hepatitis C Manifesto:

Did dreams come true?

Access to prevention, testing, treatment and care for people who use drugs

Eberhard Schatz, Katrin Schiffer, Mags Maher, Magdalena Harris, Xavier Major Roca,
Mojca Maticic and Astrid Leicht


streep tussen2


Urgent action to fight hepatitis C in people

who inject drugs in Europe

John F. Dillon, Jeffrey V. Lazarus and Homie A. Razavi



streep tussen2


The time to foster a unified global response

to the hepatitis C epidemic is now!

  • Develop Targeted HCV Strategies and Action Plans
  • Provide Access to HCV Testing, Treatment and Care Services
  • Scale-up Harm Reduction, evidence and rights and Community-Based Programs
  • Decriminalize People Who Use Drugs
  • Meaningful inclusion of People who Inject Drugs and their organisations
  • Increase Health and HCV Literacy



streep tussen2


Hepatitis C among drug users in Europe:

epidemiology, treatment and prevention

EMCDDA, Lisbon, July 2016

HepC insights cover pageEMCDDA published a new INSIGHT report: epidemiology, treatment and prevention provides a timely contribution to raising awareness of the hepatitis C epidemic in Europe and the opportunities now opening up to tackle this problem decisively. A state of the art review of the epidemiology of hepatitis C virus (HCV) infection in Europe and an overview of the way preventive measures are currently implemented in European countries set the scene. International experts address the treatment of HCV infection among people who inject drugs, with an emphasis on how we encourage uptake and deliver effective outcomes. Implementation issues are also explored, as are the complementary roles of treatment and prevention. The new medicines and treatment regimens driving the transformation in the HCV treatment landscape are reviewed in detail. The challenges of scaling up HCV treatment and successfully involving drug using patients is explored from different viewpoints, including that of the drug user.

Read more: